| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8922428 | Clinical and Translational Radiation Oncology | 2018 | 6 Pages |
Abstract
In high-grade gliomas treated with concurrent temozolomide and radiation, pretreatment neutrophilia may be a significant prognosis factor for overall survival. In addition with previously available markers, this independent cost-effective biomarker could help identifying patients with worsened prognosis.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Antoine Schernberg, Alexandre Nivet, Frédéric Dhermain, Samy Ammari, Alexandre Escande, Johan Pallud, Guillaume Louvel, Eric Deutsch,